Yahoo Finance EN

Morgan Stanley Lowers Personalis (PSNL) Price Target to $10

Mar 24, 2026 &03432424202631; 14:43 UTC finance.yahoo.com Trending 2/5

Read original on finance.yahoo.com ↗

↘

Negative for markets

Sentiment score: -65/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Morgan Stanley downgraded Personalis (PSNL) price target to $10, a bearish signal for the genomics/precision medicine stock. The downgrade is fresh (30min old) and represents a clear negative catalyst, though market reaction timing remains uncertain.

AI CONFIDENCE

62% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

PSNL

PSNLStock

Expected to decline

Morgan Stanley price target cut to $10 is a fresh bearish catalyst; genomics/precision medicine stocks are sentiment-sensitive and analyst downgrades typically trigger selling pressure within 24h

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

PSNL likely to gap down or sell into weakness over next 4-6 hours as institutional investors digest the downgrade. Confirm current PSNL price vs $10 target before trading; if already near target, downside is limited. Consider SHORT only if stock trades >5% above $10 target. [MOVE:2.5%]

KEY SIGNALS

Analyst downgrade (Morgan Stanley)Price target reductionFresh catalyst (30min)VIX stable (no panic spike yet)Broad market flat (no offsetting rally)

SECTORS INVOLVED

HealthcareBiotechnologyGenomics

Analysis generated on Mar 24, 2026 at 15:13 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Yahoo Finance. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Morgan Stanley Lowers Personalis (PSNL) Price Target to $10

RELATED INTELLIGENCE